Erratum to: Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial) (Clinical and Experimental Nephrology, (2018), 22, 1, (78-84), 10.1007/s10157-017-1427-4)

Hideki Kato, Masaomi Nangaku, Hideki Hirakata, Takashi Wada, Terumasa Hayashi, Hiroshi Sato, Yasushi Yamazaki, Takao Masaki, Tatsuo Kagimura, Hiroyasu Yamamoto, Hiroki Hase, Masahiro Kamouchi, Enyu Imai, Kyoichi Mizuno, Manabu Iwasaki, Tadao Akizawa, Yoshiharu Tsubakihara, Shoichi Maruyama, Ichiei Narita

Research output: Contribution to journalComment/debate

Abstract

The article Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal prognosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial), written by Hideki Kato, Masaomi Nangaku, Hideki Hirakata, Takashi Wada, Terumasa Hayashi, Hiroshi Sato, Yasushi Yamazaki, Takao Masaki, Tatsuo Kagimura, Hiroyasu Yamamoto, Hiroki Hase, Masahiro Kamouchi, Enyu Imai, Kyoichi Mizuno, Manabu Iwasaki, Tadao Akizawa, Yoshiharu Tsubakihara, Shoichi Maruyama, and Ichiei Narita was originally published electronically on the publisher’s internet portal (currently SpringerLink) on June 28, 2017 without open access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on August 15, 2017 to

Original languageEnglish
Pages (from-to)85-86
Number of pages2
JournalClinical and Experimental Nephrology
Volume22
Issue number1
DOIs
Publication statusPublished - Feb 1 2018

Fingerprint

Hematinics
Nephrology
Chronic Renal Insufficiency
Anemia
Clinical Trials
Kidney
Research
Internet
Darbepoetin alfa

All Science Journal Classification (ASJC) codes

  • Physiology
  • Nephrology
  • Physiology (medical)

Cite this

Erratum to : Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial) (Clinical and Experimental Nephrology, (2018), 22, 1, (78-84), 10.1007/s10157-017-1427-4). / Kato, Hideki; Nangaku, Masaomi; Hirakata, Hideki; Wada, Takashi; Hayashi, Terumasa; Sato, Hiroshi; Yamazaki, Yasushi; Masaki, Takao; Kagimura, Tatsuo; Yamamoto, Hiroyasu; Hase, Hiroki; Kamouchi, Masahiro; Imai, Enyu; Mizuno, Kyoichi; Iwasaki, Manabu; Akizawa, Tadao; Tsubakihara, Yoshiharu; Maruyama, Shoichi; Narita, Ichiei.

In: Clinical and Experimental Nephrology, Vol. 22, No. 1, 01.02.2018, p. 85-86.

Research output: Contribution to journalComment/debate

Kato, Hideki ; Nangaku, Masaomi ; Hirakata, Hideki ; Wada, Takashi ; Hayashi, Terumasa ; Sato, Hiroshi ; Yamazaki, Yasushi ; Masaki, Takao ; Kagimura, Tatsuo ; Yamamoto, Hiroyasu ; Hase, Hiroki ; Kamouchi, Masahiro ; Imai, Enyu ; Mizuno, Kyoichi ; Iwasaki, Manabu ; Akizawa, Tadao ; Tsubakihara, Yoshiharu ; Maruyama, Shoichi ; Narita, Ichiei. / Erratum to : Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial) (Clinical and Experimental Nephrology, (2018), 22, 1, (78-84), 10.1007/s10157-017-1427-4). In: Clinical and Experimental Nephrology. 2018 ; Vol. 22, No. 1. pp. 85-86.
@article{daff50f72ffa4c31863e0c66f05a3d1a,
title = "Erratum to: Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial) (Clinical and Experimental Nephrology, (2018), 22, 1, (78-84), 10.1007/s10157-017-1427-4)",
abstract = "The article Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal prognosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial), written by Hideki Kato, Masaomi Nangaku, Hideki Hirakata, Takashi Wada, Terumasa Hayashi, Hiroshi Sato, Yasushi Yamazaki, Takao Masaki, Tatsuo Kagimura, Hiroyasu Yamamoto, Hiroki Hase, Masahiro Kamouchi, Enyu Imai, Kyoichi Mizuno, Manabu Iwasaki, Tadao Akizawa, Yoshiharu Tsubakihara, Shoichi Maruyama, and Ichiei Narita was originally published electronically on the publisher’s internet portal (currently SpringerLink) on June 28, 2017 without open access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on August 15, 2017 to",
author = "Hideki Kato and Masaomi Nangaku and Hideki Hirakata and Takashi Wada and Terumasa Hayashi and Hiroshi Sato and Yasushi Yamazaki and Takao Masaki and Tatsuo Kagimura and Hiroyasu Yamamoto and Hiroki Hase and Masahiro Kamouchi and Enyu Imai and Kyoichi Mizuno and Manabu Iwasaki and Tadao Akizawa and Yoshiharu Tsubakihara and Shoichi Maruyama and Ichiei Narita",
year = "2018",
month = "2",
day = "1",
doi = "10.1007/s10157-017-1461-2",
language = "English",
volume = "22",
pages = "85--86",
journal = "Clinical and Experimental Nephrology",
issn = "1342-1751",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Erratum to

T2 - Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial) (Clinical and Experimental Nephrology, (2018), 22, 1, (78-84), 10.1007/s10157-017-1427-4)

AU - Kato, Hideki

AU - Nangaku, Masaomi

AU - Hirakata, Hideki

AU - Wada, Takashi

AU - Hayashi, Terumasa

AU - Sato, Hiroshi

AU - Yamazaki, Yasushi

AU - Masaki, Takao

AU - Kagimura, Tatsuo

AU - Yamamoto, Hiroyasu

AU - Hase, Hiroki

AU - Kamouchi, Masahiro

AU - Imai, Enyu

AU - Mizuno, Kyoichi

AU - Iwasaki, Manabu

AU - Akizawa, Tadao

AU - Tsubakihara, Yoshiharu

AU - Maruyama, Shoichi

AU - Narita, Ichiei

PY - 2018/2/1

Y1 - 2018/2/1

N2 - The article Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal prognosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial), written by Hideki Kato, Masaomi Nangaku, Hideki Hirakata, Takashi Wada, Terumasa Hayashi, Hiroshi Sato, Yasushi Yamazaki, Takao Masaki, Tatsuo Kagimura, Hiroyasu Yamamoto, Hiroki Hase, Masahiro Kamouchi, Enyu Imai, Kyoichi Mizuno, Manabu Iwasaki, Tadao Akizawa, Yoshiharu Tsubakihara, Shoichi Maruyama, and Ichiei Narita was originally published electronically on the publisher’s internet portal (currently SpringerLink) on June 28, 2017 without open access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on August 15, 2017 to

AB - The article Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal prognosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial), written by Hideki Kato, Masaomi Nangaku, Hideki Hirakata, Takashi Wada, Terumasa Hayashi, Hiroshi Sato, Yasushi Yamazaki, Takao Masaki, Tatsuo Kagimura, Hiroyasu Yamamoto, Hiroki Hase, Masahiro Kamouchi, Enyu Imai, Kyoichi Mizuno, Manabu Iwasaki, Tadao Akizawa, Yoshiharu Tsubakihara, Shoichi Maruyama, and Ichiei Narita was originally published electronically on the publisher’s internet portal (currently SpringerLink) on June 28, 2017 without open access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on August 15, 2017 to

UR - http://www.scopus.com/inward/record.url?scp=85028955991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028955991&partnerID=8YFLogxK

U2 - 10.1007/s10157-017-1461-2

DO - 10.1007/s10157-017-1461-2

M3 - Comment/debate

AN - SCOPUS:85028955991

VL - 22

SP - 85

EP - 86

JO - Clinical and Experimental Nephrology

JF - Clinical and Experimental Nephrology

SN - 1342-1751

IS - 1

ER -